Max NieuwdorpFollowAmsterdam University Medical Centers1 paperORCID 0000-0002-1926-7659OpenAlexPapersEuropean Heart JournalHuman trial·29 SepPotential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetesGLP-1 receptor agonists
European Heart JournalHuman trial·29 SepPotential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetesGLP-1 receptor agonists